| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/14/2002 | CN1363327A Nano medicine 'Zhuangyao Jianshen' and its preparing process |
| 08/14/2002 | CN1363324A Nano medicine 'Zhishu' and its preparing process |
| 08/14/2002 | CN1363320A Nano medicine 'Yanghe' and its preparing process |
| 08/14/2002 | CN1363318A Capsule 'Jingmaitong' |
| 08/14/2002 | CN1363307A Nano medicine 'Guiluningshen' and its preparing process |
| 08/14/2002 | CN1363306A Nano compound prunella spike medicine and its preparing process |
| 08/14/2002 | CN1363305A Nano compound fleece flower root-rehmannia root medicine and its preparing process |
| 08/14/2002 | CN1363304A Nano medicine for strengthening patient's resistance and nourishing essence and its preparing process |
| 08/14/2002 | CN1363303A Nano medicine 'Compound Sanju' for treating cold and its preparing process |
| 08/14/2002 | CN1363302A Nano medicine 'Fangfeng Tongsheng' and its preparing process |
| 08/14/2002 | CN1363301A Nano medicine 'Ermiao' and its preparing process |
| 08/14/2002 | CN1363299A Nano medicine 'Shenfu' and its preparing process |
| 08/14/2002 | CN1363295A Nano medicine 'Yougui' and its preparing process |
| 08/14/2002 | CN1363287A Nano Wuling medicine and its preparing process |
| 08/14/2002 | CN1363282A Multifunctional 'Baikuang Kangti Powder' |
| 08/14/2002 | CA2371487A1 Tricyclic sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371481A1 Sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371480A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 08/13/2002 | US6433197 Reacting arylhydroxy compound and an epoxy compound to form an epoxy-aryl ether; reacting epoxy-aryl ether with active methylene compound to form a lactone; reducing to provide hydroxy-substituted tetrahydrofuran |
| 08/13/2002 | US6433183 (R)-3-(4-bromobenzyl)-1-(3,5-dichlorophenyl)-3-methyl-1,6-dihydroimidazo[1,2-a]imidazole-2,5-dione |
| 08/13/2002 | US6433179 Process for producing paroxetine |
| 08/13/2002 | US6433175 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6433155 Isolated cdna or rna polynucleotide comprising nucleic acid sequence encoding polypeptide comprising specified amino acid sequence, or fragment thereof |
| 08/13/2002 | US6433149 Compounds and methods for inhibiting cancer metastasis |
| 08/13/2002 | US6433139 Secreted protein HPEAD48 |
| 08/13/2002 | US6433135 Polyoxyethylene glycol luteinizing hormone releasing hormone bound for serine |
| 08/13/2002 | US6433027 Medicament compositions based on tiotropium bromide and formoterol fumarate |
| 08/13/2002 | US6433021 Antiinflammatory agents; mast cell stabilizers |
| 08/13/2002 | US6433019 Administering a nitric oxide donor to treat neurodegenerative disorders |
| 08/13/2002 | US6433018 Method for reducing hypertrophy and ischemia |
| 08/13/2002 | US6433005 Selective cox ii inhibitor |
| 08/13/2002 | US6433004 Substituted β,γ-anellated lactones |
| 08/13/2002 | US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 08/13/2002 | US6433000 Aromatic sulfamate derivatives as sulfatase inhibitors; estrogen receptor blockers; breast cancer treatment |
| 08/13/2002 | US6432996 Pharmaceutical composition |
| 08/13/2002 | US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents |
| 08/13/2002 | US6432989 Use of CRF antagonists to treat circadian rhythm disorders |
| 08/13/2002 | US6432984 Cannabinoid receptor antagonists; treatment of obesity, drug addiction, alcholism, psychological, and eating disorders |
| 08/13/2002 | US6432983 Treating estrogen-dependent cancer, endometriosis, osteoporosis, post-menopausal disorders and hyperlipidemia; restenosis inhibitors |
| 08/13/2002 | US6432978 4-hydroxy-1-methyl-1,2-dihydroquinolin-2-one derivatives; cardiovascular, atopic, and rheumatic disorders; antiallergens, antiinflammatory agents, antiasthmatics, and hypotensive agents |
| 08/13/2002 | US6432977 Salts of quinoline derivatives as NK3 antagonists |
| 08/13/2002 | US6432975 Aromatic alkylene azobicyclic compounds as nicotinic receptor antagonists; antidepressants; nervous system disorder treatment |
| 08/13/2002 | US6432972 Desloratadine as non-sedating antihistamine, decongestant |
| 08/13/2002 | US6432957 Piperazine derivative |
| 08/13/2002 | US6432954 Central nervous system disorders |
| 08/13/2002 | US6432952 Central nervous system disorders; antiinflammatory agents |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/13/2002 | US6432931 Compositions and methods for inhibiting bone resorption |
| 08/13/2002 | US6432922 Antitumor agents; angiogenesis inhibitors |
| 08/13/2002 | US6432917 Anticancer agents |
| 08/13/2002 | US6432687 Polypeptide amino acid sequence with immunoactive segments |
| 08/13/2002 | US6432659 Motor proteins and methods for their use |
| 08/13/2002 | US6432456 Contains as an effective component a water-soluble component of capsicum annuum l.var.grossumn which is a solanacede plant. |
| 08/13/2002 | US6432454 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 08/13/2002 | US6432447 Core of fluvastatin, hydroxypropyl methyl cellulose and optionally other excipients, dosage form is color-stable during storage |
| 08/13/2002 | US6432445 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 08/13/2002 | US6432401 Administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing anesthesia with a low dose of an alpha adrenergic receptor antagonist; use in hair graft procedures, for example |
| 08/13/2002 | US6432146 Use of a combination of two cationic dyes for the direct dyeing of keratin fibers |
| 08/13/2002 | CA2269947C Covalent polar lipid conjugates for targeting |
| 08/13/2002 | CA2202513C Allosteric modulators of the nmda receptor |
| 08/13/2002 | CA2088994C Therapeutically active mixture of glutathion and anthocyan compounds |
| 08/12/2002 | WO2001034196A2 Mixture containing rare earths and use thereof |
| 08/12/2002 | CA2398832A1 Mixture containing rare earths and use thereof |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | WO2002061083A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/08/2002 | WO2002060972A2 Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof |
| 08/08/2002 | WO2002060951A2 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor viii |
| 08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 08/08/2002 | WO2002060949A2 Glycoforms a fas ligand inhibitory protein analog |
| 08/08/2002 | WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 08/08/2002 | WO2002060932A2 A serpin in bifidobacteria |
| 08/08/2002 | WO2002060931A2 A fimbria-like gene in bifidobacteria |
| 08/08/2002 | WO2002060926A2 Hepatitis c tripeptide inhibitors |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060892A1 Ethanolates of sodium-hydrogen exchanger type-1 inhibitor |
| 08/08/2002 | WO2002060890A1 Novel physiologically active substances |
| 08/08/2002 | WO2002060885A1 Chemical compounds |
| 08/08/2002 | WO2002060879A2 Bacterial gyrase inhibitors and uses thereof |
| 08/08/2002 | WO2002060877A1 Imidazole derivatives |
| 08/08/2002 | WO2002060876A1 Triaryl compounds and utilization thereof |
| 08/08/2002 | WO2002060871A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 08/08/2002 | WO2002060869A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough |
| 08/08/2002 | WO2002060863A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060491A2 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 08/08/2002 | WO2002060489A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | WO2002060479A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
| 08/08/2002 | WO2002060472A1 Remedies for hyponutrition status |